Skip to main content
OpenTrials

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

870 public trials 211 recruiting studies
Refine in advanced search Browse all conditions

TDP-43 Proteinopathies trial results

Completed

A Phase 2 Study to Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRONT-2)

NCT03987295

Conditions
Brain Diseases, Central Nervous System Diseases, Dementia, +10 more
Locations
  • UCSF San Francisco, California, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • The Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases UT Health San Antonio San Antonio, Texas, United States
View Trial Details
Completed

MIROCALS: Modifying Immune Response and OutComes in ALS

NCT03039673

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • CHRU de Lille - Hôpital Roger Salengro Lille, France
  • CHU de Limoges - Hôpital Dupuytren Limoges, France
  • HCL - Hôpital Neurologique P. Wertheimer Lyon, France
  • APHM - Hôpital de la Timone Marseille, France
View all 17 locations
View Trial Details

Related conditions